Delta Medical Showcases at SIAGASCOT, Marking the First International Exhibition of 2026

  • 23 March 2026

First Exhibition

In 2026, Delta Medical officially kicked off its global exhibition journey by participating in SIAGASCOT, marking the company’s first international academic event of the year. As one of the most influential orthopaedic congresses in Italy, SIAGASCOT gathers leading experts in orthopaedics and sports medicine from across Europe and beyond, providing a high-level platform for academic exchange and innovation.

At the exhibition, Delta Medical presented a range of core products and solutions, demonstrating its technological expertise and continuous innovation in sports medicine and arthroscopy. The booth attracted strong interest and active engagement from international attendees.

Expert Recognition

During the exhibition, Delta Medical welcomed visits from several renowned shoulder specialists. Among them was Prof. Pascal Boileau from France, a leading shoulder surgeon, Professor of Orthopaedic Surgery, and senior consultant at the Institute for Sports and Reconstructive Surgery (ICR), Nice, as well as Chairman of the internationally renowned Nice Shoulder Course. During his visit, Prof. Boileau showed great interest in the showcased products and engaged in in-depth discussions with the team on product design and clinical applications.
Dr. Giorgio Ippolito, an Italian shoulder specialist from the Orthopaedic and Traumatologic Surgical Institute (ICOT), Latina, and Chairman of the Shoulder 360° International Meeting, also visited the booth. He focused particularly on the application of the products in shoulder arthroscopy and trauma reconstruction, and spoke positively about their design concepts and clinical relevance.

The recognition and engagement from these experts underscore Delta Medical’s growing influence and product strength in the global sports medicine field.

Delta Medical remains committed to advancing sports medicine technologies and strengthening international academic collaboration. Moving forward, the company will continue to work closely with global experts to deliver more efficient and reliable clinical solutions.